0001628280-23-023956.txt : 20230629 0001628280-23-023956.hdr.sgml : 20230629 20230629192229 ACCESSION NUMBER: 0001628280-23-023956 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230627 FILED AS OF DATE: 20230629 DATE AS OF CHANGE: 20230629 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Williams Laura A CENTRAL INDEX KEY: 0001869194 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36485 FILM NUMBER: 231058919 MAIL ADDRESS: STREET 1: 116 HUNTINGTON AVENUE, 6TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ARDELYX, INC. CENTRAL INDEX KEY: 0001437402 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 34175 ARDENWOOD BLVD. CITY: FREMONT STATE: CA ZIP: 94555 BUSINESS PHONE: 510-745-7047 MAIL ADDRESS: STREET 1: 34175 ARDENWOOD BLVD. CITY: FREMONT STATE: CA ZIP: 94555 FORMER COMPANY: FORMER CONFORMED NAME: NTERYX INC DATE OF NAME CHANGE: 20080611 4 1 wk-form4_1688080938.xml FORM 4 X0407 4 2023-06-27 0 0001437402 ARDELYX, INC. ARDX 0001869194 Williams Laura A C/O ARDELYX, INC. 400 FIFTH AVENUE, SUITE 210 WALTHAM MA 02451 0 1 0 0 Chief Medical Officer 0 Common Stock 2023-06-27 4 S 0 25000 3.3453 D 294430 D This transaction was executed in multiple trades in prices ranging from $3.331 to $3.365, inclusive. The price reported in Column 4 above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. /s/ Elizabeth Grammer, Attorney-in-Fact for Laura A. Williams 2023-06-29